Information Provided By:
News For TNDM;MDT From the Last 2 Days
Jul 6, 2022 | 06:17 EDT
Wolfe Research analyst Mike Polark initiated coverage of Medtronic with an Underperform rating and $85 price target. The stock gets assigned a Low multiple, but his "gut says 'potential value trap'," Polark tells investors. In a relative-to-rest-of-coverage rating system, it is difficult to digest an EPS CAGR back 10 years of about 5% and a dividend that has yielded about 2% per year over same period and "conclude other than Underperform," Polark argues.